Although these factors will affect Omron's free cash flow generation in fiscal 2024, we expect this to be temporary and the company's financial health to return to its normal state over the medium ...

We maintain our fair value estimate of JPY 7,400 for wide-moat Omron as our midterm outlook for the company’s margin expansion remains intact. While revenue dropped by 1% year on year in the ...

Amidst a backdrop of global market fluctuations driven by tariff uncertainties and mixed economic indicators, the tech sector continues to capture investor interest with its potential for high growth.

Introduction to Digital Health and WellnessThe digital health and wellness industry is experiencing significant growth as healthcare increasingly incorporates technology to improve the quality, ...

Oppo Watch X2 debuts with seamless hypertension risk assessment, advanced health tracking, dual-frequency GPS, and eSIM support. Starts at 2,499 yuan ($343) in China.

Europe encoder market was valued at $ 727.2 million in 2023 and will grow by 8.1% annually over 2023-2033. The growth is driven by the increased need for high-level automation acr ...

OMRON Healthcare is a global leader in the field of clinically proven, innovative medical equipment for home health monitoring and treatment. Aiming to realize its vision "Going for Zero, Preventive ...

Health2Sync Deepens Reach and Partnerships in South Korea with Growing Adoption of its Digital Disease Management Platform ...

Malaysian community pharmacy chain Alpro Pharmacy has partnered with blood pressure (BP) monitoring company OMRON Healthcare in an effort to improve BP and hypertension management in Malaysia.

South Korea's bioimpedance sensor market thrives on government funding, technological innovation, wearable integration, and healthcare adoption, driv ...